ABOUT US
Bostal LLC (“BL”, formerly AustarPharma), is a pharmaceutical company specializing in enabling drug delivery platform technologies. Since its inception, BL has been devoted to enhancing performance and adding value to successful drug products in the pharmaceutical market and those yet to be launched. Founded by Dr. Ron Liu in Edison, NJ, USA, in 2004, the company is supported by a team of highly experienced professionals. Our management team has an average of over 20 years of experience in the pharmaceutical industry.
Bostal Drug Delivery (“BDD”) founded by Dr. Ron Liu in Guangzhou, China, 2013.
OUR GOAL
To be the global leader in long-acting injectables by leveraging proprietary drug delivery technologies to develop high-impact, differentiated LAI products that improve patient outcomes and deliver strong commercial value.
MISSION
To enhance the lives of patients worldwide by developing long-acting injectable therapies that are safer, more effective, and more convenient — powered by cutting-edge drug delivery technologies and scientific excellence.
VISION
To be the world’s most trusted innovator in long-acting injectables, transforming proven molecules into next-generation therapies that redefine treatment standards across multiple therapeutic areas.
CORE VALUES
1. Innovation
We challenge convention through science-driven innovation in drug delivery and
formulation.
2. Quality
We are committed to the highest standards in product performance, safety, and
manufacturing.
3. Integrity
We uphold transparency, ethics, and accountability in all our partnerships and
operations.
4. Patient Focus
Every decision we make centers on improving patient health, adherence, and
outcomes.
5. Collaboration
We partner globally to accelerate access to meaningful therapies and expand
impact.
6. Execution
Excellence
We deliver on our promises with speed, precision, and operational rigor.
WHAT MAKES US SPECIAL
OUR PRODUCTS
Bostal develops differentiated long-acting injectable (LAI) formulations by applying proprietary drug delivery technologies to both new and established molecules. With a highly experienced R&D team and integrated development capabilities, we advance high-barrier products from concept to commercialization with speed and precision.
505(b)(2) Product Introduction
Our robust pipeline features a portfolio of innovative long-acting injectable (LAI) candidates addressing neuropsychiatric conditions, metabolic diseases, and other high-value therapeutic areas. We actively seek global collaborations and commercial partnerships to accelerate the development of these therapies and deliver impactful solutions to patients worldwide.
WHY CHOOSE US
Bostal is a trusted partner for pharmaceutical companies seeking to co-develop or commercialize advanced LAI therapies built on enabling platform technologies.
·
Strategic Partnerships
We collaborate with global partners
to unlock the full potential of high-value LAI products through shared
innovation, development, and commercialization.
·
Regulatory and IP Expertise
Our deep knowledge of U.S.
regulatory pathways and formulation-based patent strategies ensures competitive
positioning and long-term value.
·
Execution Excellence
From early development to
commercial manufacturing, our integrated operations ensure quality, speed, and
compliance at every stage.
·
Innovation-Driven Growth
We focus on technically advanced
products that meet real-world clinical needs and deliver meaningful market
differentiation.
·
Experienced Team
Led by industry veterans, our
multidisciplinary team brings scientific depth and executional rigor to every
collaboration.